Medivation Inc (MDVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Medivation Inc (Medivation) is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The companys only product XTANDI developed for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). The company with collaboration with Astellas conducts studies for the treatment of enzalutamide in prostate cancer, advanced breast cancer, and hepatocellular carcinoma. The company offers its product to pharmaceuticals, biotechnology drugs and medical devices. It operates along with its subsidiaries in the US and in the UK. Medivation is headquartered in San Francisco, California, the US.
Medivation Inc (MDVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Medivation Inc (Medivation) is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The companys only product XTANDI developed for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). The company with collaboration with Astellas conducts studies for the treatment of enzalutamide in prostate cancer, advanced breast cancer, and hepatocellular carcinoma. The company offers its product to pharmaceuticals, biotechnology drugs and medical devices. It operates along with its subsidiaries in the US and in the UK. Medivation is headquartered in San Francisco, California, the US.
Medivation Inc (MDVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medivation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medivation Inc, Medical Devices Deals, 2011 to YTD 2017 9
Medivation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medivation Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Medivation Acquires Rights to Talazoparib from BioMarin Pharma 11
Licensing Agreements 12
Medivation Exercises Option for Licensing Agreement with CureTech for Pidilizumab 12
Debt Offering 13
Medivation Completes Public Offering Of 2.625% Convertible Senior Notes Due 2017 For US$259 Million 13
Acquisition 15
Pfizer Acquires Medivation in Tender Offer 15
Medivation Inc - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
May 05, 2016: Sanofi Sends Letter to Medivations Board 21
Financial Announcements 22
Aug 09, 2016: Medivation Reports Second Quarter 2016 Financial Results 22
May 05, 2016: Medivation Reports First Quarter 2016 Financial Results 24
Feb 25, 2016: Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance 26
Corporate Communications 29
Mar 28, 2016: Jennifer Jarrett to Join Medivation as Chief Financial Officer 29
Jan 11, 2016: Medivation Names Marion McCourt Chief Operating Officer 30
Legal and Regulatory 31
May 27, 2016: Medivation Files Preliminary Consent Revocation Statement 31
Government and Public Interest 33
Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivations Board 33
Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivations Board of Directors 34
Other Significant Developments 35
May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivations Board 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
Medivation Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medivation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medivation Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Medivation Inc, Medical Devices Deals, 2011 to YTD 2017 9
Medivation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medivation Acquires Rights to Talazoparib from BioMarin Pharma 11
Medivation Exercises Option for Licensing Agreement with CureTech for Pidilizumab 12
Medivation Completes Public Offering Of 2.625% Convertible Senior Notes Due 2017 For US$259 Million 13
Pfizer Acquires Medivation in Tender Offer 15
Medivation Inc, Key Competitors 18
Medivation Inc, Key Employees 19
Medivation Inc, Subsidiaries 20
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23
Table of Contents 2
List of Tables 3
List of Figures 4
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medivation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medivation Inc, Medical Devices Deals, 2011 to YTD 2017 9
Medivation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medivation Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Medivation Acquires Rights to Talazoparib from BioMarin Pharma 11
Licensing Agreements 12
Medivation Exercises Option for Licensing Agreement with CureTech for Pidilizumab 12
Debt Offering 13
Medivation Completes Public Offering Of 2.625% Convertible Senior Notes Due 2017 For US$259 Million 13
Acquisition 15
Pfizer Acquires Medivation in Tender Offer 15
Medivation Inc - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
May 05, 2016: Sanofi Sends Letter to Medivations Board 21
Financial Announcements 22
Aug 09, 2016: Medivation Reports Second Quarter 2016 Financial Results 22
May 05, 2016: Medivation Reports First Quarter 2016 Financial Results 24
Feb 25, 2016: Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance 26
Corporate Communications 29
Mar 28, 2016: Jennifer Jarrett to Join Medivation as Chief Financial Officer 29
Jan 11, 2016: Medivation Names Marion McCourt Chief Operating Officer 30
Legal and Regulatory 31
May 27, 2016: Medivation Files Preliminary Consent Revocation Statement 31
Government and Public Interest 33
Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivations Board 33
Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivations Board of Directors 34
Other Significant Developments 35
May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivations Board 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List Of Tables
Medivation Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medivation Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medivation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medivation Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Medivation Inc, Medical Devices Deals, 2011 to YTD 2017 9
Medivation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medivation Acquires Rights to Talazoparib from BioMarin Pharma 11
Medivation Exercises Option for Licensing Agreement with CureTech for Pidilizumab 12
Medivation Completes Public Offering Of 2.625% Convertible Senior Notes Due 2017 For US$259 Million 13
Pfizer Acquires Medivation in Tender Offer 15
Medivation Inc, Key Competitors 18
Medivation Inc, Key Employees 19
Medivation Inc, Subsidiaries 20
List Of Figures
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23
RELATED REPORTS
Medivation Inc - Strategic SWOT Analysis Review
Medivation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on
View ReportMedivation Inc - Strategic SWOT Analysis Review
Medivation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
